Skip to main content
Book cover

Kinins V pp 153–157Cite as

Kallikrein-Kinin System in Infectious Diseases

  • Chapter
  • 22 Accesses

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 247 A))

Abstract

Infectious disease including those caused by viruses, rickettsia, fungi, parasites and bacteria are known to be associated with hemostatic disorders1 including disseminated intravascular coagulation (DIC). This paper will concentrate on the pathogenesis of the coagulation abnormalities in particular changes in surface mediated events of plasma proteolysis. Most of the work that will be discussed will concern our studies on gram-negative septicemia since this is the most dramatic of the infectious disorders, and on typhoid fever in which controlled observations have been made. A new approach to therapy using a genetically engineered protease inhibitor will be illustrated in an animal model.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J. G. Kelton and P. B. Neame, Hemorrhagic complications of infection, in: “Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 2nd ed.,” R. W. Colman, J. Hirsch, V. Marder, E. Salzman, eds., J. B. Lippincott, Philadelphia (1987).

    Google Scholar 

  2. A. S. Nies, R. P. Forsyth, H. E. Williams and K. L. Melmon, Contribution of kinin to endotoxic shock in unanesthesized Rhesus monkeys, Circ Res. 22: 155 (1968).

    Article  PubMed  CAS  Google Scholar 

  3. J. Margolis, Activation of plasma by contact with glass: Evidence for a common reaction which releases plasma kinin and initiates coagu-lation, J. Physiol. 44: 1 (1958)

    Google Scholar 

  4. R. W. Colman, S. J. Robboy and J. D. Minna, Disseminated intravascular coagulation: A reappraisal, Ann Rev. Med. 30: 359 (1979).

    Article  PubMed  CAS  Google Scholar 

  5. J. W. Mason, U. R. Kleeberg, P. Dolan and R. W. Colman, Plasma kalli-krein and Hageman factor in gram negative bacteremia, Ann Int. Med. 73: 545 (1970).

    PubMed  CAS  Google Scholar 

  6. T. F. O’Donnell, G. H. A. Clowes, R. C. Talamo and R. W, Colman, Kinin activation in the blood of patients with septic man, Surg Gyn. Obst. 143: 539 (1976).

    PubMed  Google Scholar 

  7. A. Weisser, G. H. A. Clowes, R. W. Colman and R. C. Talamo, Therapy: The lung in shock, in “New Aspects of Trasylol Sepsis and Endo-toxemia in Pigs: A Comparison of Mortality and Pathophysiology,” Schattauer, Verlag (1973).

    Google Scholar 

  8. R. W. Colman, S. J. Robboy and J. D. Minna, Disseminated intravascular coagulation: An approach, Am. J. Med. 52: 679 (1972).

    Article  PubMed  CAS  Google Scholar 

  9. J. W. Mason and R. W. Colman, The role of Hageman factor is disseminated intravascular coagulation induced by septicemia, neoplasia or liver disease, Thromb Diath. Hemorr. 26: 325 (1971).

    CAS  Google Scholar 

  10. R. W. Colman, R. Edelman, C. F. Scott and R. H. Gilman, Plasma kalli-krein activation and inactivation during typhoid fever, J. Clin Inv. 61: 287 (1978)

    Article  CAS  Google Scholar 

  11. M. C. Owen, O. Brennan, J. H. Lewis and R. W. Carrel, Mutation of antitrypsin to antithrombin: α1 antitrypsin Pittsburgh (358 Met-Arg), New ng. J. Med. 309: 694 (1983).

    Article  CAS  Google Scholar 

  12. C.F. Scott, R. W. Carrell, C. B. Glaser, F. Kueppers, J. H. Lewis and R. W. Colman, α1-antitrypsin-Pittsburgh: A potent inhibitor of human plasma factor IXa, kallikrein and factor Xllf, J. Clin. Inv. 77: 631 (1986).

    Article  CAS  Google Scholar 

  13. M. Schapira, M. A. Ramus, S. Jallat, D. Carvallo and M. Courtney, Recombinant α1-antitrypsin Pittsburgh (Met358-Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment, J. Clin Inv. 77: 635 (1986)

    Article  CAS  Google Scholar 

  14. R. W. Colman, D. W. Flores, R. A. de la Cadena, C.F. Scott, L. Cousens, P. J. Barr, I. B. Hoffman, F. Kueppers, D. Fisher, S. Idell and J. Pisarello, Recombinant alpha-1-antitrypsin Pittsburgh attenuates expérimentale-négative septicemia, Am J. Path, (in press) (1987).

    Google Scholar 

  15. Y. Wachtfogel, U. Kuchich, J. Greenplate, P. Gluszko, W. Abrams, G. Weinbaum, R. K, Wenger, B. Rucinski, S. Niewiarowski, L. H. Edmunds and R. W. Caiman, Human neutrophil degranulation during extracorporeal circulation, Blood 69: 324 (1987).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Plenum Press, New York

About this chapter

Cite this chapter

Colman, R.W. (1989). Kallikrein-Kinin System in Infectious Diseases. In: Abe, K., Moriya, H., Fujii, S. (eds) Kinins V. Advances in Experimental Medicine and Biology, vol 247 A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9543-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-9543-4_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-9545-8

  • Online ISBN: 978-1-4615-9543-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics